This article was automatically generated by Dow Jones using technology from Automated Insights.
The following companies are among those expected to report their latest financial results before the market opens.
EchoStar Corp.'s fourth-quarter EPS is forecast at a loss of 46 cents. Adjusted EPS is forecast at a loss of 64 cents.
Norwegian Cruise Line Holdings Ltd.'s fourth-quarter EPS is forecast at 21 cents, compared with 52 cents in the prior-year period. Adjusted EPS is forecast at 27 cents.
AAON Inc.'s fourth-quarter EPS is forecast at 43 cents, compared with 30 cents in the prior-year period. Adjusted EPS is forecast at 45 cents.
ADT Inc.'s fourth-quarter EPS is forecast at 21 cents, compared with 20 cents in the prior-year period. Adjusted EPS is forecast at 22 cents.
Sealed Air Corp.'s fourth-quarter EPS is forecast at 67 cents, compared with a loss of 5 cents in the prior-year period. Adjusted EPS is forecast at 74 cents.
California Resources Corp.'s fourth-quarter EPS is forecast at 45 cents, compared with 36 cents in the prior-year period. Adjusted EPS is forecast at 51 cents.
Apogee Therapeutics Inc.'s fourth-quarter EPS is forecast at a loss of 99 cents. Adjusted EPS is forecast at a loss of $1.05.
TEGNA Inc.'s fourth-quarter EPS is forecast at 46 cents, compared with $1.11 in the prior-year period. Adjusted EPS is forecast at 43 cents.
Turning Point Brands Inc.'s fourth-quarter EPS is forecast at 87 cents, compared with 13 cents in the prior-year period.
Biohaven Ltd.'s fourth-quarter EPS is forecast at a loss of $1.19, compared with a loss of $1.85 in the prior-year period.
Xeris Biopharma Holdings Inc.'s fourth-quarter EPS is forecast at 2 cents, compared with a loss of 3 cents in the prior-year period. Adjusted EPS is forecast at 0.03 cents.
UroGen Pharma Ltd.'s fourth-quarter EPS is forecast at a loss of 50 cents, compared with a loss of 80 cents in the prior-year period.
ArriVent BioPharma Inc.'s fourth-quarter EPS is forecast at a loss of 88 cents, compared with a loss of 61 cents in the prior-year period. Adjusted EPS is forecast at a loss of 85 cents.
Annexon Inc.'s fourth-quarter EPS is forecast at a loss of 32 cents, compared with a loss of 33 cents in the prior-year period.
PepGen Inc.'s fourth-quarter EPS is forecast at a loss of 41 cents, compared with a loss of 68 cents in the prior-year period. Adjusted EPS is forecast at a loss of 37 cents.
Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.
(END) Dow Jones Newswires
March 02, 2026 05:31 ET (10:31 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.